Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV000457329 | SCV000563986 | pathogenic | Lynch syndrome | 2016-05-12 | criteria provided, single submitter | clinical testing | This variant is a gross deletion of the genomic region encompassing exons 3-6 of the MSH6 gene. This leads to an in-frame deletion, preserving the integrity of the reading frame. This variant has not been reported in the literature in individuals with a MSH6-related disease. Although the integrity of the reading frame is preserved, this deletion is expected to result in the loss of 1033 amino acid residues of the MSH6 protein (p.Ser154_Gly1186del). Deletion of this region results in the loss of the N-terminal portion of the MSH2 interaction region and the ATP-binding domain, two regions that are important for MSH6 protein function (PMID: 9774676, 12019211, 9564049). For these reasons, this variant has been classified as Pathogenic. |
Department of Pathology and Laboratory Medicine, |
RCV000457329 | SCV000591005 | pathogenic | Lynch syndrome | criteria provided, single submitter | clinical testing |